Dr. Mohamed Elhassan Akoad, MD

Dr. Akoad practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Akoad's NPI, 1295751949, was assigned on July 14, 2006. Dr. Akoad graduated from University of Khartoum Faculty of Medicine in 1991. Dr. Akoad holds Massachusetts license 210063.

Dr. Akoad's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Akoad's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Akoad to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akoad practices. Vendor and product names are available with a free account.

Surgery is Dr. Akoad's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Akoad is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Akoad's licenses on file in 5 states: Massachusetts, Florida, New Hampshire, Pennsylvania and New York.

Dmand AI lists abdominal hernia repair surgery and kidney transplant among the conditions Dr. Akoad treats.

CMS data shows 203 Medicare services from Dr. Akoad across 3 procedure codes in 2024, for 72 Medicare patients. Medicare paid $13,917 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Akoad in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 72% have chronic kidney disease. 35% are also on Medicaid. Their average risk score is 5.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akoad's median patient age at 64, with 40% women.

In 2024, Dr. Akoad wrote 142 Medicare Part D claims for 29 patients. 89% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $4,121 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Akoad for performance year 2024, reported through an alternative payment model (APM). Dr. Akoad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Akoad, published from 2011 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Liver Transplantation, Hepatectomy and Liver. Dr. Akoad has published most often in Liver Transpl. Dr. Akoad's most frequent co-authors are Elizabeth A. Pomfret, MD, PhD, James Pomposelli, MD and Jawad Ahmad, MD.

Dmand AI links Dr. Akoad to 1 clinical trial. Conditions studied include End Stage Liver Disease and Liver Failure.

CMS Open Payments shows 31 general payments to Dr. Akoad from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 42% of the total. Medtronic, Inc. paid the most, $1,238.

Dmand AI lists 2 awards for Dr. Akoad, most recently Boston Magazine in 2013.

Dr. Akoad graduated from University of Khartoum Faculty of Medicine in 1991. Dr. Akoad is a member of ACS.

Dr. Akoad is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.